Jubilant Life Sciences rises as its arm to launch unsecured high yield bonds

26 Sep 2016 Evaluate

Jubilant Life Sciences is currently trading at Rs 644.35, up by 8.20 points or 1.29% from its previous closing of Rs 636.15 on the BSE.

The scrip opened at Rs. 638.00 and has touched a high and low of Rs. 650.00 and Rs. 626.35 respectively. So far 70298 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 650.00 on 26-Sep-2016 and a 52 week low of Rs. 272.50 on 20-Jan-2016.

Last one week high and low of the scrip stood at Rs. 650.00 and Rs. 580.40 respectively. The current market cap of the company is Rs. 10257.71 crore.

The promoters holding in the company stood at 54.02%, while Institutions and Non-Institutions held 26.82% and 19.15% respectively.

Jubilant Life Sciences’ material wholly-owned subsidiary ‘Jubilant Pharma’ (JPL), has received an approval to launch a benchmark offering of unsecured high yield bonds outside India, under Regulation S of the US Securities Act. The bonds are proposed to be listed on the Singapore Exchange Securities Trading. The board of directors at its meeting held on September 23, 2016 has approved for the same.

Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.

Jubilant Pharmova Share Price

1061.95 -25.45 (-2.34%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×